187 related articles for article (PubMed ID: 19009655)
1. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma.
Dhingra S; Feng W; Brown RE; Zhou Z; Khoury T; Zhang R; Tan D
Int J Clin Exp Pathol; 2011; 4(8):733-41. PubMed ID: 22135720
[TBL] [Abstract][Full Text] [Related]
3. CD44V6 in gastric carcinoma: a marker of tumor progression.
Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
6. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
[TBL] [Abstract][Full Text] [Related]
7. HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.
Murdaca G; Calamaro P; Lantieri F; Pigozzi S; Mastracci L; Grillo F; Magnani O; Ceppa P; Puppo F; Fiocca R
Virchows Arch; 2018 Oct; 473(4):425-433. PubMed ID: 29845360
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma.
Zhao P; Li Y; Lu Y
BMC Cancer; 2010 May; 10():218. PubMed ID: 20487522
[TBL] [Abstract][Full Text] [Related]
9. De-novo expression of CD44 and survival in gastric cancer.
Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
[TBL] [Abstract][Full Text] [Related]
10. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
11. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas.
Hong RL; Lee WJ; Shun CT; Chu JS; Chen YC
Oncology; 1995; 52(4):334-9. PubMed ID: 7539903
[TBL] [Abstract][Full Text] [Related]
14. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
16. CD44(+) CD324(-) expression and prognosis in gastric cancer patients.
Cao L; Hu X; Zhang J; Liang P; Zhang Y
J Surg Oncol; 2014 Nov; 110(6):727-33. PubMed ID: 24910454
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
Yoo CH; Noh SH; Kim H; Lee HY; Min JS
J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
[TBL] [Abstract][Full Text] [Related]
18. Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?
Kouraklis G; Katsoulis IE; Theocharis S; Tsourouflis G; Xipolitas N; Glinavou A; Sioka C; Kostakis A
Dig Dis Sci; 2009 May; 54(5):1015-20. PubMed ID: 19058005
[TBL] [Abstract][Full Text] [Related]
19. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
20. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133.
Feitosa NPP; Pereira VBM; Silva BGB; Queroz AVF; Rodrigues BJ; Costa MLV; Alencar CH; Lima-Júnior RCP; Wong DVT; Frota CC; Almeida PRC
Acta Histochem; 2021 Oct; 123(7):151787. PubMed ID: 34517259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]